Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

BUY
$14.0 - $22.6 $2.11 Million - $3.41 Million
150,805 Added 172.14%
238,412 $5.23 Billion
Q1 2025

May 15, 2025

BUY
$17.82 - $28.42 $321,757 - $513,151
18,056 Added 25.96%
87,607 $1.6 Billion
Q4 2024

Feb 14, 2025

SELL
$15.04 - $25.72 $740,885 - $1.27 Million
-49,261 Reduced 41.46%
69,551 $1.68 Billion
Q3 2024

Nov 14, 2024

BUY
$12.79 - $17.23 $1.28 Million - $1.73 Million
100,382 Added 544.67%
118,812 $1.94 Billion
Q2 2024

Aug 14, 2024

BUY
$11.74 - $17.71 $19,371 - $29,221
1,650 Added 9.83%
18,430 $296 Million
Q1 2024

May 15, 2024

SELL
$11.46 - $15.04 $33,096 - $43,435
-2,888 Reduced 14.68%
16,780 $228 Million
Q4 2023

Feb 14, 2024

BUY
$10.06 - $14.8 $197,860 - $291,086
19,668 New
19,668 $277 Million

Others Institutions Holding WRBY

About Warby Parker Inc.


  • Ticker WRBY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 95,777,000
  • Market Cap $1.62B
  • Description
  • Warby Parker Inc. provides eyewear products. It offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, and contact lenses, as well as accessories, including cases, lenses kit with anti-fog spray, pouches, and anti-fog lens spray. The company also offers eye exams and vision tests directly to consumers through its re...
More about WRBY
Track This Portfolio

Track Nebula Research & Development LLC Portfolio

Follow Nebula Research & Development LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nebula Research & Development LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nebula Research & Development LLC with notifications on news.